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Cerebral venous and sinus thrombosis is a relatively rare condition with a variable presentation that can translate into a diﬃcult
workup and a delay in diagnosis and treatment. We describe the successful use of mechanical thrombectomy and thrombolysis in
the case of an eighteen-year-old woman that presented with progressive thrombosis of the jugular veins and dural sinuses despite
adequateanticoagulation.OurcasehighlightstheneedforclinicianstoincludeCVSTintheinitialdiﬀerentialdiagnosisofpatients
in order to prevent delays and poor outcomes.
1.Introduction
Cerebral venous and sinus thrombosis (CVST) is a relatively
rare clinical condition aﬀecting about 5 people per million
[1] and complicated by a nonspeciﬁc, highly variable presen-
tation that can lead to a signiﬁcant delay in diagnosis [1, 2].
Misdiagnosis and delay in diagnosis are common, with an
initial misdiagnosis occurring in up to 73% of patients and
delays exceeding 10 days in 40% of patients [3]. In the West-
ern world, the main causes of CVST are genetic or acquired
prothrombotic factors, whereas infection predominates the
clinicalpictureindevelopingcountries[2,4,5].Asaresultof
gender-speciﬁc acquired risk factors, a female predominance
among patients suﬀering CVST has been documented [2],
with a ratio of 3:1 women to men in young to middle-aged
adults [4]. Here we report a challenging diagnostic workup
for a case of progressive thrombosis of the jugular veins and
dural sinuses despite adequate anticoagulation, necessitating
mechanical thrombectomy and thrombolysis. A successful
outcome was achieved.
2.CaseReport
An 18-year-old woman was transferred to our tertiary care
hospitalafterpresentingtoacommunityEmergencyDepart-
ment (ED) with increased intraocular pressure (IOP), pa-
pilledema, accompanied by bilateral jugular vein thrombosis
(JVT)andduralvenoussinusthrombosis(DVST)conﬁrmed
by head CT scan. On arrival, the patient presented with
blurred vision, more speciﬁcally progressive loss of vision on
the left side upon closing right eye. Of note, the patient’s
mother had a history of diabetes mellitus, hypertension, and
dyslipidemia and had experienced a possible CVA at age 33.
The patient herself has a history signiﬁcant for morbid obe-
sity, polycystic ovarian syndrome, and insulin resistance. The
patient denied any history of smoking, tobacco, drugs, or
alcohol use, as well as any speech abnormalities, dysphagia,
tingling, numbness, weakness, bowel or bladder inconti-
nence.
Two months prior to admission (PTA), the patient had
started taking a third-generation oral contraceptive pill
(OCP), norgestimate and ethinyl estradiol tablets, which2 Case Reports in Medicine
Figure 1: MRI of brain with contrast demonstrating ﬂuid and
enhancement within the mastoids, more extensive on the left,
suggestive of mastoiditis.
was stopped 3 weeks later after she developed headaches.
One month PTA, the patient developed an “extremely bad”
headache, followed by nausea/vomiting, bilateral neck pain,
and right ear pain prompting presentation to ED where
antibiotics were prescribed for suspected acute otitis media.
Two weeks later, the patient returned to the ED with similar
symptoms and was subsequently diagnosed with bilateral
mastoiditis; tympanostomy tubes were placed bilaterally.
Symptoms persisted, however, and she subsequently devel-
oped blurred vision prompting her return to the ED for a
third time, two days later. A head CT scan with contrast
demonstrated left jugular venous thrombosis prompting
hospitaladmission.ThepatientwasplacedonIVCoumadin,
with a Lovenox bridge. She was subsequently discharged
on Coumadin (5mg PO daily) and Lovenox (100mg subQ
BID) and was referred to an ophthalmologist. Six days after
hospital discharge, the ophthalmologist noted her to have
increased IOP along with papilledema. She was emergently
referred to the ED, where a head CT scan demonstrated ex-
tensionofthethromboticprocesstoincludetheduralvenous
sinus and bilateral jugular veins. These ﬁndings prompted
the patient’s transfer to our care for further evaluation and
treatment.
Neurological evaluation demonstrated papilledema and
markedly impaired left eye vision, with no other focal neu-
rological deﬁcits. Coagulation studies demonstrated supra-
therapeutic anticoagulation levels with PT 33.5, INR 3.6,
and APTT 33. Blood work including CBC and electrolytes
was normal. Cardiolipin screen and blood cultures (x2) were
negative. A hypercoagulability work-up screening for anti-
thrombin III levels, protein C and S, factor VIII, factor V
Leiden, lupus anticoagulant, prothrombin G210A mutation,
and homocysteine returned unremarkable. MRI of the brain
with and without contrast revealed no evidence of an acute
ischemic event but did show evidence of dural and cortical
venous thrombosis and ﬁndings consistent with mastoiditis
(see Figure 1). MR venography (MRV) of the head without
contrast demonstrated DST with areas of apparent collater-
alization and recanalization (see Figure 2).
Figure 2: MRV of head without contrast demonstrating absence
of normal ﬂow-related enhancement within the sagittal, transverse,
and left sigmoid sinus suggestive of dural sinus thrombosis. There
are small adjacent dural vessels in proximity to these thrombosed
sinuses.
Interventional radiology was consulted for mechanical
thrombectomy and thrombolysis with tissue plasminogen
activator (tPA), both of which were successfully performed.
Ophthalmological evaluation after the procedure demon-
strated no aﬀerent papillary defect, clearing of papilledema,
and decreased visual acuity bilaterally with left eye 20/100
and right eye 20/200. Follow-up CT cerebral angiography
revealed improvement in the appearance of both transverse
venous sinuses and the superior sagittal sinus when com-
pared to previous images. The patient’s vision continued to
improve, and she was discharged home on Coumadin (5mg
daily) with directions to follow up with an ophthalmologist.
3. Discussion
In this case, the patient’s nonspeciﬁc presentation resulted in
a delay of two weeks from symptom onset to the diagnosis of
left jugular vein thrombosis and oﬀers a number of teaching
points.Areviewofcommonpresentations,etiology,workup,
andtreatmentwillfollowtohelpclinicianseﬀectivelyinclude
CVST in their diﬀerential diagnosis and to prevent a delay in
diagnosis which may result in poor outcomes.
TheinitialsignsandsymptomsofCVSTcanmimicmore
common disorders causing a delay in diagnosis [1]. The clin-
ical picture typically falls under one of four distinct syn-
dromes: (1) isolated intracranial hypertension, (2) focal neu-
rological deﬁcits, (3) encephalopathy, and (4) cavernous si-
n u ss y n d r o m e[ 1, 2]. Each syndrome has its own unique
clinical presentation: intracranial hypertension presents with
headache with or without papilledema and visual distur-
bances, focal neurological deﬁcits with hemi- or monopare-
sis, encephalopathy with an altered level of consciousness,
and cavernous sinus syndrome with oculomotor nerve pals-
ies [2]. Of the various presenting symptoms the most com-
mon is headache [2–6], as seen in our patient. The clinical
picture is also dependent on the time elapsed from symptom
onset to presentation for medical care, as patients with aCase Reports in Medicine 3
chroniccourseordelayedpresentationcanshowpapilledema
w h i c hi sl e s sc o m m o ni na c u t ec a s e s[ 1].
In addition to a variable clinical presentation, the etiol-
o g yo fC V S Ti sc o m m o n l ym u l t i f a c t o r i a l[ 1, 7], with a large
portion of patients having more than one cause or predis-
posing factor [1, 3, 8]. Our patient’s recent history of starting
a third-generation OCP and its temporal relationship to the
onset of headaches should have warranted that CVST at least
be included in the diﬀerential diagnosis. Oral contraceptives
are a well-known risk factor for CVST [2–5] with third-
generation contraceptives substantially increasing the risk of
venous thrombosis and CVST [2, 9]. In an International
Study on Cerebral Vein and Dural Sinus Thrombosis, 54% of
the 381 women younger than 50 years of age had oral contra-
ceptive use as a risk factor [8]. In hindsight, mastoiditis was
another clue to the diagnosis of CVST, due to the fact that
mastoiditisisaknowncauseoflateralvenoussinusthrombo-
sis (LST) [10]. A retrospective review of otogenic LST at The
Children’s Hospital of Philadelphia found that such patients
most commonly presented with headache and a history of
treatment for acute otitis media (6–60 days). In about 60%
ofthecases,symptomslasted>2weeks[6].Otherriskfactors
include antithrombin deﬁciency, protein C and S deﬁciency,
factorVLeidenmutation,hyperhomocysteinemia,nephrotic
syndrome, antiphospholipid antibody syndrome, pregnancy,
the puerperium, and meningitis [5].
As part of the workup of CVST, a hypercoagulable
workupshouldbeperformed,preferablybeforetheinitiation
of anticoagulation therapy, since heparin and warfarin can
alter some lab results [11]. Although our patient had had an
unremarkable hypercoagulable workup, she presented to us
already on warfarin and will require further conﬁrmatory
labs after warfarin is stopped. In searching for an etiology,
imaging is typically used. With our patient, a head CT scan
was the initial imaging study; however, magnetic resonance
imaging is the most sensitive tool for detecting CVST [2, 3]
and subtraction angiography the gold standard [3]. The
combination of MR angiography and venography is now the
ﬁrst imaging choice for diagnosing CVST [2, 6]. Depending
on the time course of CVST, the MR imaging signal ap-
pearance is variable with isointense T1-weighted images and
hypointense T2-weighted images during the ﬁrst 3–5 days.
After the ﬁrst 5 days, the T1- and T2-weighted MR images
are of high intensity, whereas one month after such images
may become variable or appear isointense [2].
Current therapy is centered on identifying and managing
any underlying predisposing factors; management of ele-
vatedintracranialpressureandcerebraledema;symptomatic
treatment for seizures, headaches, and visual disturbance;
achieving appropriate anticoagulation, even in the presence
of intracranial hemorrhage [2, 3, 12]. Endovascular treat-
ment of CVST is not currently included in the existing treat-
mentguidelines andshouldprobablybe alastresortreserved
for selected severe cases [2], as it was used in our patient. A
number of case reports have described the use of urokinase
or recombinant tPA in cases where anticoagulation was
unsuccessful; however, the reports noted that such patients
experienced higher rates of intracranial hemorrhages, espe-
ciallywhenpreexistingintracerebralhemorrhagewaspresent
[2]. Despite this concern, mechanical thrombectomy has
shown promising results and still presents an attractive op-
tion even in patients with preexisting intracranial hemor-
rhage [3, 12–14]. In 2009, Rahman et al. [12] published
a recommended treatment algorithm for CVST that used
GCS cutoﬀs for systemic anticoagulation versus tPA infusion
and/or thrombectomy. Until randomized clinical trials are
undertaken, it must be understood that this procedure is still
considered investigational.
In summary, our case highlights the need for clinicians
to include CVST in the initial diﬀerential diagnosis of pa-
tients in order to prevent delays and poor outcomes. Such
patients include young women with a history of recent
initiationofanoralcontraceptive,mastoiditis,alteredvision,
or neurological deﬁcits. Physicians should have a lower
threshold for ordering neuroimaging studies when faced
with the scenario described above. In addition, we report the
successful use of mechanical thrombectomy and throm-
bolysis with tPA in the face of failure of anticoagulation
treatment.
Abbreviations
CVST: Cerebral venous and sinus thrombosis
DVST: Dural venous sinus thrombosis
JVT: Jugular vein thrombosis
LST: Lateral venous sinus thrombosis
MRV: MR venography
PTA: Prior to admission
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tPA: Tissue plasminogen activator.
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